Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 2, 2014, Pages 592-594.e1

  Cagigi, Alberto ^a   Rinaldi, Stefano ^b   Di Martino, Angela ^c   Manno, Emma Concetta ^a   Zangari, Paola ^a   Aquilani, Angela ^a   Cotugno, Nicola ^a   Nicolosi, Luciana ^a   Villani, Alberto ^a   Bernardi, Stefania ^a   Donatelli, Isabella ^c   Pahwa, Savita ^d   Rossi, Paolo ^a   Palma, Paolo ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; INFLUENZA VACCINE; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CROSS REACTION; CYTOKINE PRODUCTION; HEMAGGLUTINATION INHIBITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPHENOTYPING; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LETTER; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; OUTCOME ASSESSMENT; PREMATURE AGING; PREMATURE IMMUNE SENESCENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEASONAL INFLUENZA; TREATMENT RESPONSE; VIRUS LOAD;

ADOLESCENT; AGING; AGING, PREMATURE; ANTIBODIES, VIRAL; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RECEPTORS, INTERLEUKIN-2; VACCINATION; YOUNG ADULT;

EID: 84895057775     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.10.003     Document Type: Article

References (9)

1. A. Cagigi, N. Cotugno, C. Giaquinto, L. Nicolosi, S. Bernardi, and P. Rossi et al. Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions Hum Vaccin Immunother 8 2012 1784 1794
2. S. Khurana, D. Frasca, B. Blomberg, and H. Golding AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans PLoS Pathog 8 2012 e1002920
3. A. Cagigi, S. Pensieroso, N. Ruffin, S. Sammicheli, R. Thorstensson, and Q. Pan-Hammarstrom et al. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients Vaccine 31 2013 2231 2237
4. G. Colonna-Romano, M. Bulati, A. Aquino, M. Pellicano, S. Vitello, and D. Lio et al. A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people Mech Ageing Dev 130 2009 681 690
5. A. Cagigi, L. Du, L.V. Dang, S. Grutzmeier, A. Atlas, and F. Chiodi et al. CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection PLoS One 4 2009 e5427
6. S. Pallikkuth, S. Pilakka Kanthikeel, S.Y. Silva, M. Fischl, R. Pahwa, and S. Pahwa Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy J Immunol 186 2011 6173 6181
7. S. Pallikkuth, S.P. Kanthikeel, S.Y. Silva, M. Fischl, R. Pahwa, and S. Pahwa Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients J Allergy Clin Immunol 128 2011 1279 1285
8. S. Moir, A. Malaspina, J. Ho, W. Wang, A.C. Dipoto, and M.A. O'Shea et al. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease J Infect Dis 197 2008 572 579
9. S. Pallikkuth, A. Parmigiani, S.Y. Silva, V.K. George, M. Fischl, and R. Pahwa et al. Impaired peripheral blood T follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine Blood 120 2012 985 993